Lithuania to join EU joint procurement mechanism for COVID-19 vaccines

0 Comment(s)Print E-mail Xinhua, September 24, 2020
Adjust font size:

VILNIUS, Sept. 23 (Xinhua) -- Lithuania decided on Wednesday to purchase a possible vaccine against COVID-19 via the European Commission's (EC) joint procurement mechanism, the government said in a release.

It was also decided to diversify purchases from different manufacturers selected by the EC and with which the EC had already reached preliminary vaccine purchase and sale agreements.

"We will not take risks by guessing which of the companies currently leading in clinical trials will be the first to develop the vaccine," Prime Minister Saulius Skvernelis was quoted as saying in the release.

"If we do that, we may be left without any vaccine, which would be a real tragedy for Lithuania."

He noted that the vaccine purchasing conditions are agreed on by the EC and chances to change them are very limited.

As of Sept. 17, there were 182 COVID-19 candidate vaccines being developed worldwide, and 36 of them were in clinical trials, according to the World Health Organization. Several vaccines from the U.S., Britain, China, and Germany are in phase-3 trials. Enditem

Follow China.org.cn on Twitter and Facebook to join the conversation.
ChinaNews App Download
Print E-mail Bookmark and Share

Go to Forum >>0 Comment(s)

No comments.

Add your comments...

  • User Name Required
  • Your Comment
  • Enter the words you see:   
    Racist, abusive and off-topic comments may be removed by the moderator.
Send your storiesGet more from China.org.cnMobileRSSNewsletter